Claybrook Capital’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $169K | Sell |
10,026
-3,500
| -26% | -$59.1K | 0.1% | 133 |
|
|
2023
Q2 | $186K | Hold |
13,526
| – | – | 0.1% | 135 |
|
|
2023
Q1 | $307K | Buy |
13,526
+3,500
| +35% | +$79.5K | 0.17% | 108 |
|
|
2022
Q4 | $236K | Hold |
10,026
| – | – | 0.15% | 114 |
|
|
2022
Q3 | $261K | Hold |
10,026
| – | – | 0.17% | 107 |
|
|
2022
Q2 | $220K | Hold |
10,026
| – | – | 0.13% | 121 |
|
|
2022
Q1 | $450K | Hold |
10,026
| – | – | 0.22% | 97 |
|
|
2021
Q4 | $430K | Hold |
10,026
| – | – | 0.2% | 102 |
|
|
2021
Q3 | $667K | Buy |
+10,026
| New | +$667K | 0.34% | 76 |
|
|
2021
Q2 | – | Sell |
-10,026
| Closed | -$686K | – | 178 |
|
|
2021
Q1 | $686K | Hold |
10,026
| – | – | 0.4% | 64 |
|
|
2020
Q4 | $673K | Hold |
10,026
| – | – | 0.44% | 55 |
|
|
2020
Q3 | $516K | Hold |
10,026
| – | – | 0.39% | 53 |
|
|
2020
Q2 | $378K | Hold |
10,026
| – | – | 0.32% | 61 |
|
|
2020
Q1 | $299K | Buy |
+10,026
| New | +$299K | 0.27% | 61 |
|